TALK vs. PGNY, TDOC, FTRE, NHC, VRDN, AHCO, CDNA, AGL, PNTG, and AVAH
Should you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include Progyny (PGNY), Teladoc Health (TDOC), Fortrea (FTRE), National HealthCare (NHC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), agilon health (AGL), The Pennant Group (PNTG), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry.
Talkspace vs.
Progyny (NASDAQ:PGNY) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, community ranking, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.
Progyny has higher revenue and earnings than Talkspace. Talkspace is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.
Progyny presently has a consensus target price of $25.00, suggesting a potential upside of 19.05%. Talkspace has a consensus target price of $4.38, suggesting a potential upside of 44.87%. Given Talkspace's stronger consensus rating and higher possible upside, analysts clearly believe Talkspace is more favorable than Progyny.
94.9% of Progyny shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 12.3% of Progyny shares are held by insiders. Comparatively, 21.7% of Talkspace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Progyny has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.
In the previous week, Progyny had 13 more articles in the media than Talkspace. MarketBeat recorded 20 mentions for Progyny and 7 mentions for Talkspace. Progyny's average media sentiment score of 0.62 beat Talkspace's score of 0.37 indicating that Progyny is being referred to more favorably in the media.
Progyny received 95 more outperform votes than Talkspace when rated by MarketBeat users. Likewise, 71.43% of users gave Progyny an outperform vote while only 41.67% of users gave Talkspace an outperform vote.
Progyny has a net margin of 5.03% compared to Talkspace's net margin of -0.76%. Progyny's return on equity of 11.36% beat Talkspace's return on equity.
Summary
Progyny beats Talkspace on 14 of the 19 factors compared between the two stocks.
Get Talkspace News Delivered to You Automatically
Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Talkspace Competitors List
Related Companies and Tools
This page (NASDAQ:TALK) was last updated on 1/20/2025 by MarketBeat.com Staff